Quality control of human ABCG2 protein in the endoplasmic reticulum: Ubliquitination and proteasomal degradation

被引:35
作者
Wakabayashi-Nakao, Kanako [1 ]
Tamura, Ai [1 ]
Furukawa, Tomoka [1 ]
Nakagawa, Hiroshi [1 ]
Ishikawa, Toshihisa [1 ]
机构
[1] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biomol Engn, Midori Ku, Yokohama, Kanagawa 2268501, Japan
关键词
ERAD; Ubiquitin; Proteasome; Endosome; Lysosome; N-glycosylation; Disulfide bond; CANCER RESISTANCE PROTEIN; SINGLE-NUCLEOTIDE POLYMORPHISMS; CASSETTE TRANSPORTER ABCG2; ER-ASSOCIATED DEGRADATION; N-LINKED GLYCOSYLATION; MEMBRANE LOCALIZATION; PLASMA-MEMBRANE; CYSTIC-FIBROSIS; EXPRESSION; GENE;
D O I
10.1016/j.addr.2008.08.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Human ATP-binding cassette (ABC) transporter ABCG2 (BCRP/MXR/ABCP) is a plasma membrane protein carrying intra- and inter-molecular disulfide bonds and an Winked glycan. Both disulfide bond formation and N-glycosylation are critical check points determining the stability and degradation fate of ABCG2 protein in the endoplasmic reticulum (ER). Misfolded ABCG2 protein without those post-translational modifications is removed from the ER by retrotranslocation to the cytosol compartment, ubiquitination by ubiquitin ligase, and finally degradation by proteasomes. Certain non-synonymous SNP variants of ABCG2 undergo such ER-associated degradation (ERAD). (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 55 条
[1]   PRINCIPLES THAT GOVERN FOLDING OF PROTEIN CHAINS [J].
ANFINSEN, CB .
SCIENCE, 1973, 181 (4096) :223-230
[2]   Genetic variation in the ATP-binding Cassette Transporter gene ABCG2 (BCRP) in a Swedish population [J].
Bäckström, G ;
Taipalensuu, J ;
Melhus, H ;
Brändström, H ;
Svensson, AC ;
Artursson, P ;
Kindmark, A .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 18 (05) :359-364
[3]   Detection of single nucleotide polymorphisms in the ABCG2 gene in a Dutch population [J].
Bosch, TM ;
Kjellberg, LM ;
Bouwers, A ;
Koeleman, BPC ;
Schellens, JHM ;
Beijnen, JH ;
Smits, PHM ;
Meijerman, I .
AMERICAN JOURNAL OF PHARMACOGENOMICS, 2005, 5 (02) :123-131
[4]   Pharmacogenetics of ABCG2 and adverse reactions to gefitinib [J].
Cusatis, George ;
Gregorc, Vanesa ;
Li, Jing ;
Spreafico, Anna ;
Ingersoll, Roxann G. ;
Verweij, Jaap ;
Ludovini, Vienna ;
Villa, Eugenio ;
Hidalgo, Manuel ;
Sparreboom, Alex ;
Baker, Sharyn D. .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (23) :1739-1742
[5]   ABCG2 pharmacogenetics: Ethnic differences in allele frequency and assessment of influence on irinotecan disposition [J].
de Jong, FA ;
Marsh, S ;
Mathijssen, RHJ ;
King, C ;
Verweij, J ;
Sparreboom, A ;
McLeod, HL .
CLINICAL CANCER RESEARCH, 2004, 10 (17) :5889-5894
[6]   Role of pharmacogenetics in irinotecan therapy [J].
de Jong, FA ;
de Jonge, MJA ;
Verweij, J ;
Mathijssen, RHJ .
CANCER LETTERS, 2006, 234 (01) :90-106
[7]   N-linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membrane [J].
Diop, NK ;
Hrycyna, CA .
BIOCHEMISTRY, 2005, 44 (14) :5420-5429
[8]   Setting the standards: Quality control in the secretory pathway [J].
Ellgaard, L ;
Molinari, M ;
Helenius, A .
SCIENCE, 1999, 286 (5446) :1882-1888
[9]   ER quality control: towards an understanding at the molecular level [J].
Ellgaard, L ;
Helenius, A .
CURRENT OPINION IN CELL BIOLOGY, 2001, 13 (04) :431-437
[10]  
FURUKAWA T, PHARM RES IN PRESS